These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 33846775)

  • 1. Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review).
    Lampis A; Ratti M; Ghidini M; Mirchev MB; Okuducu AF; Valeri N; Hahne JC
    Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33846775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer.
    Ghidini M; Lampis A; Mirchev MB; Okuducu AF; Ratti M; Valeri N; Hahne JC
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33383713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
    Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
    Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy for esophageal cancer: a 2019 update.
    Schizas D; Charalampakis N; Kole C; Mylonas KS; Katsaros I; Zhao M; Ajani JA; Psyrri A; Karamouzis MV; Liakakos T
    Immunotherapy; 2020 Feb; 12(3):203-218. PubMed ID: 32208794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option.
    Ren Y; Miao JM; Wang YY; Fan Z; Kong XB; Yang L; Cheng G
    Front Immunol; 2022; 13():961796. PubMed ID: 35911673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A good start of immunotherapy in esophageal cancer.
    Zhao Q; Yu J; Meng X
    Cancer Med; 2019 Aug; 8(10):4519-4526. PubMed ID: 31231980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
    Shi T; Song X; Wang Y; Liu F; Wei J
    Front Immunol; 2020; 11():683. PubMed ID: 32411132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.
    Picard E; Verschoor CP; Ma GW; Pawelec G
    Front Immunol; 2020; 11():369. PubMed ID: 32210966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstituting Immune Surveillance in Breast Cancer: Molecular Pathophysiology and Current Immunotherapy Strategies.
    Cilibrasi C; Papanastasopoulos P; Samuels M; Giamas G
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging immunotherapy for the treatment of esophageal cancer.
    Jackie Oh S; Han S; Lee W; Lockhart AC
    Expert Opin Investig Drugs; 2016 Jun; 25(6):667-77. PubMed ID: 26950826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination strategies to maximize the benefits of cancer immunotherapy.
    Zhu S; Zhang T; Zheng L; Liu H; Song W; Liu D; Li Z; Pan CX
    J Hematol Oncol; 2021 Sep; 14(1):156. PubMed ID: 34579759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application.
    Zheng R; Liu X; Zhang Y; Liu Y; Wang Y; Guo S; Jin X; Zhang J; Guan Y; Liu Y
    Front Immunol; 2024; 15():1383978. PubMed ID: 38756774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines.
    Roudko V; Cimen Bozkus C; Greenbaum B; Lucas A; Samstein R; Bhardwaj N
    Front Immunol; 2021; 12():757804. PubMed ID: 34630437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in gastrointestinal cancer: The current scenario and future perspectives.
    Abdul-Latif M; Townsend K; Dearman C; Shiu KK; Khan K
    Cancer Treat Rev; 2020 Aug; 88():102030. PubMed ID: 32505807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for colorectal cancer.
    Yu B; Kang J; Lei H; Li Z; Yang H; Zhang M
    Front Immunol; 2024; 15():1433315. PubMed ID: 39238638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in Gastro-Oesophageal Cancer: Current Practice and the Future of Personalised Therapy.
    Booth ME; Smyth EC
    BioDrugs; 2022 Jul; 36(4):473-485. PubMed ID: 35384619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of Esophageal Cancer: Current Status, Many Trials and Innovative Strategies.
    Alsina M; Moehler M; Lorenzen S
    Oncol Res Treat; 2018; 41(5):266-271. PubMed ID: 29705786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Immunotherapies for Glioblastoma Multiforme.
    Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
    Front Immunol; 2020; 11():603911. PubMed ID: 33767690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.
    Moehler M; Delic M; Goepfert K; Aust D; Grabsch HI; Halama N; Heinrich B; Julie C; Lordick F; Lutz MP; Mauer M; Alsina Maqueda M; Schild H; Schimanski CC; Wagner AD; Roth A; Ducreux M
    Eur J Cancer; 2016 May; 59():160-170. PubMed ID: 27039171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy for oesophagogastric cancer.
    Davidson M; Chau I
    Expert Opin Biol Ther; 2016 Oct; 16(10):1197-207. PubMed ID: 27409159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.